Hoth Therapeutics shareholders re-elect board, ratify auditor, approve equity plan increase

Hoth Therapeutics, Inc.

All five incumbent directors re-elected; vote totals ranged from 637,415 to 700,399 for each.
Ratification of WithumSmith+Brown as auditor passed with 1,763,403 votes for (79.1% of votes cast).
Amendment to 2022 Omnibus Equity Plan approved to increase reserved shares from 591,317 to 1,091,317.
Quorum of 2,230,078 shares represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.